Grupo Clínico Asociado en Neurorología
Grupo Clínico Asociado
Cognitive impairment and dementias
Cerebrovascular diseases
Demyelinating diseases
Epilepsy
Extrapyramidal pathology
Pain / headaches

Coordinador
STAFF
Colaborador/a
David García LópezAna Isabel Pareja MartínezAntonio Salvador AliagaBegoña López PesqueraFrancisco Gascón GiménezJésica García UllJosé Andrés Domínguez MoránJosé María Salom JuanJosé Miguel Santonja Llabata
Enfermero/a
Miriam Iborra Perales
Técnico/a
Apoyo
Publicaciones
Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65years: a real-life multicentre analysis of 162 patients. Muñoz-Vendrell A, Campoy S, Caronna E, Alpuente A, Torres-Ferrus M, Nieves Castellanos C, Olivier M, Campdelacreu J, Prat J, Camiña Muñiz J, Molina Martínez FJ, Mínguez-Olaondo A, Ruibal Salgado M, Santos Lasaosa S, Navarro Pérez MP, Morollón N, López Bravo A, Cano Sánchez LM, García-Sánchez SM, García-Ull J, Rubio-Flores L, Gonzalez-Martinez A, Quintas S, Echavarría Íñiguez A, Gil Luque S, Castro-Sánchez MV, Adell Ortega V, García Alhama J, Berrocal-Izquierdo N, Belvís R, Díaz-Insa S, Pozo-Rosich P, Huerta-Villanueva M. The journal of Headache and Pain. 2023 Jun 2;24(1):63. doi: 10.1186/s10194-023-01585-2. PMID: 37268904
Remission of graves disease after initiation of ocrelizumab in patients with multiple sclerosis. Casany-Fernandez R, Gascon-Gimenez F, Matarredona Solaz E, Pardo Lozano F, Dominguez-Moran J, Ferri Ciscar J, Real J. Thyroid. 2023 Feb;33(2):267-269. doi: 10.1089/thy.2022.0398. PMID: 36416241
Treatment of multiple sclerosis with rituximab: a Spanish multicenter experience. Gascon-Gimenez F, Alcala C, Ramio-Torrenta L, Montero P, Matias-Guiu J, Gomez-Esteve I, Oreja-Guevara C, Gil-Perotin S, Blanco Y, Carcelen M, Quintanilla-Bordas C, Costa L, Villar L, Martinez-Rodriguez J, Dominguez J, Calles C, Gonzalez I, Sotoca J, Oterino A, Lucas-Jimenez C, Perez-Miralles F, Casanova B. Frontiers in Neurology. 2023 Mar 7;14:1060696. doi: 10.3389/fneur.2023.1060696. PMID: 36959824
Calcitonin gene-related peptide in migraine: from pathophysiology to treatment. Santos-Lasaosa S, Belvis R, Cuadrado M, Diaz-Insa S, Gago-Veiga A, Guerrero-Peral A, Huerta M, Irimia P, Lainez J, Latorre G, Leira R, Pascual J, Porta-Etessam J, Sanchez Del Rio M, Viguera J, Pozo-Rosich P. Neurologia. 2022 Jun;37(5):390-402. doi: 10.1016/j.nrleng.2019.03.025. PMID: 35672126
Case Report: exacerbation of relapses following mRNA COVID-19 vaccination in multiple sclerosis: a case series. Quintanilla-Bordas C, Gascon-Gimenez F, Alcala C, Paya M, Mallada J, Silla R, Carratala-Bosca S, Gasque-Rubio R, Castillo J, Casanova B. Frontiers in Neurology. 2022 Apr 27;13:897275. doi: 10.3389/fneur.2022.897275. PMID: 35572939
Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis. Vicente C, Lacruz L, Gascon F, Carratala S, Quintanilla-Bordas C, Sanz M, Carcelen-Gadea M, Mallada J, Carreres J, Torres L, Dominguez J, Canizares E, Gil-Perotin S, Cubas L, Rubio R, Castillo-Villalba J, Perez-Miralles F, Casanova B. Frontiers in Neurology. 2022 Oct 28;13:991596. doi: 10.3389/fneur.2022.991596. PMID: 36388220
The SEN and the Spanish model of recertification promoted by the Spanish Federation of Medical and Scientific Associations and its members. Mendibe Bilbao M, Ezpeleta Echavarri D, Lainez Andres J. Neurologia. 2022 Sep 29;S2173-5808(22)00102-X. doi: 10.1016/j.nrleng.2022.09.001. PMID: 36183954
Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis. Perez-Miralles F, Prefasi D, Garcia-Merino A, Ara J, Izquierdo G, Meca-Lallana V, Gascon-Gimenez F, Martinez-Gines M, Ramio-Torrenta L, Costa-Frossard L, Fernandez O, Moreno-Garcia S, Maurino J, Carreres-Polo J, Casanova B. Brain and Behavior. 2021 Apr;11(4):e02044. doi: 10.1002/brb3.2044. PMID: 33486890
Document of revision and updating of medication overuse headache (MOH). Gonzalez-Oria C, Belvis R, Cuadrado M, Diaz-Insa S, Guerrero-Peral A, Huerta M, Irimia P, Lainez Andrés J, Latorre G, Leira R, Oterino A, Pascual J, Porta-Etessam J, Pozo-Rosich P, Sanchez Del Rio M, Santos-Lasaosa S. Neurologia. 2021 Apr;36(3):229-240. doi: 10.1016/j.nrl.2020.04.029. PMID: 32917437
Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of Neurology and the Spanish Society of Neurosurgery. Belvis R, Irimia P, Seijo-Fernandez F, Paz J, Garcia March G, Santos-Lasaosa S, Latorre G, Gonzalez-Oria C, Rodriguez R, Pozo-Rosich P, Lainez Andrés J. Neurologia. 2021;36(1):61-79. doi: 10.1016/j.nrl.2020.04.022. PMID: 32718873
Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project. Santos Garcia D, Blazquez-Estrada M, Calopa M, Escamilla-Sevilla F, Freire E, Garcia Ruiz P, Grandas F, Kulisevsky J, Lopez-Manzanares L, Martinez Castrillo J, Mir P, Pagonabarraga J, Perez-Errazquin F, Salom J, Tijero B, Valldeoriola F, Yanez R, Aviles A, Luquin M. Brain Sciences. 2021 Jul 31;11(8):1027. doi: 10.3390/brainsci11081027. PMID: 34439646
Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs. Santamarina E, Bertol V, Garayoa V, Garcia-Gomara M, Garamendi-Ruiz I, Giner P, Aranzabal I, Piera Balbastre A, Arcos C, Esteve P, Marinas A, Garcia-Escriva A, Viloria-Alebesque A, Loro F, Ponz De Tienda A, Olivan J, Bonet M, Davila-Gonzalez P, Sivera R, Molins A, Sansa G, Roche J, Martinez A, Monteagudo S, Casadevall T. Seizure. 2020 Dec;83:48-56. doi: 10.1016/j.seizure.2020.09.026. PMID: 33096456
Evaluation of the concomitant use of oral preventive treatments and Onabotulinumtoxin A in chronic migraine: the PREVENBOX study. Alpuente A, Gallardo V, Torres-Ferrus M, Santos-Lasaosa S, Guerrero A, Lainez Andrés J, Viguera J, Gago-Veiga A, Irimia P, Del Rio M, Pozo-Rosich P. European Journal of Neurology. 2020 Oct;27(10):2102-2108. doi: 10.1111/ene.14331. PMID: 32421912
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine. Santos-Lasaosa S, Cuadrado M, Gago-Veiga A, Guerrero-Peral A, Irimia P, Lainez Andrés J, Leira R, Pascual J, Porta-Etessam J, Sánchez Del Río M, Viguera Romero J, Pozo-Rosich P. Neurologia. 2020 Oct;35(8):568-578. doi: 10.1016/j.nrl.2017.09.003. PMID: 29169811
Will neurological care change over the next 5 years due to the COVID-19 pandemic?. Matias-Guiu J, Matias-Guiu J, Alvarez-Sabin J, Ramon Ara J, Arenillas J, Casado-Naranjo I, Castellanos M, Jimenez-Hernandez M, Lainez Andrés J, Moral E, Morales A, Rodriguez-Antiguedad A, Segura T, Serrano-Castro P, Diez-Tejedor E. Neurologia. 2020 May;35(4):252-257. doi: 10.1016/j.nrl.2020.04.006. PMID: 32364126
+ Información
Doctorando: Suller Martí, Ana
Director: Láinez Andres, Jose Miguel
Fecha: 21/03/2022
Universidad: Universitat de València
Título: Tratamiento endovascular en el ictus isquémico agudo. Análisis de factores pronóstico y de identificación etiológica
Doctorando: Piera Balbastre, Ana
Director: Láinez Andres, Jose Miguel; Ponz De Tienda, Alejandro
Fecha: 15/12/2020
Universidad: Universitat de València